| Financial Year |
March 31 2023 |
| Monetary Funds |
1,881,717,490.14 |
| Held-for-trading Financial Assets |
317,047,067.30 |
| Notes Receivable |
1,102,254.92 |
| Accounts Receivable |
698,867,412.07 |
| Advances to Suppliers |
29,095,484.16 |
| Other Receivables |
25,591,720.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
557,621,235.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
170,128,453.96 |
| Total Current Assets |
3,694,439,644.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
13,959,458.28 |
| Investment Properties |
26,687,158.10 |
| Fixed Assetes |
1,053,735,734.67 |
| Under-construction Projects |
2,445,779.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
179,114,399.72 |
| R&D expenses |
-- |
| Goodwill |
87,013,553.11 |
| Long-Term Deferred and Prepaid Expenses |
3,774,973.73 |
| Deferred Income Tax Assets |
94,362,883.97 |
| Other Non-Current Assets |
100,282,691.68 |
| Sub-Total of Non-Current Assets |
1,692,403,762.38 |
| Total Assets |
5,386,843,406.87 |
| Short-Term Loans |
137,189,418.72 |
| Trading Financial liabilities |
168,905.00 |
| Notes Payable |
368,896,642.34 |
| Accounts Payable |
519,055,392.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
64,429,699.54 |
| Taxes Payable |
38,056,051.78 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
235,153,646.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
62,796,029.93 |
| Other Current Liabilities |
1,553,876.21 |
| Sub-Total of Current Liabilities |
1,461,537,640.08 |
| Long-term Loans |
56,772,299.04 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
22,470,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,374,695.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
266,061,365.14 |
| Total Liabilities |
1,727,599,005.22 |
| Paid-In Capital(Or Share Stock) |
1,414,659,630.00 |
| Capital Surplus |
164,031,336.96 |
| Surplus Reserve |
515,808,131.83 |
| LESS:Treasury Stock |
156,466,137.65 |
| Undistributed Profits |
1,689,129,595.84 |
| Minority Stockholder's Interest |
28,603,015.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,630,641,386.38 |
| Owner's Equity（Stockholder's Equity） |
3,659,244,401.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,386,843,406.87 |
